43例多发性骨髓瘤骨髓EB病毒DNA检测  

Marrow EB virus DNA detecting in 43 patients with multiple myeloma

作　　者：亓瑞先[1] 王敏[1] 卢晓[1] 

机构地区：[1]莱芜市人民医院检验科,山东莱芜271100

出　　处：《医学检验与临床》2012年第2期20-21,共2页Medical Laboratory Science and Clinics

摘　　要：目的用荧光定量PCR方法检测急性白血病（AL）与多发性骨髓瘤患者（MN）骨髓中EBV—DNA含量，并探讨其临床意义。方法采用荧光定量PCR技术检测38例急性白血病与43倒多发性骨髓瘤患者EBV感染情况，同时检测了32例对照组小细胞低色素性贫血和巨幼细胞性贫血患者骨髓EBV—DNA含量。结果多发性骨髓瘤患者EBV感染率为58．1％，急性白血病组EBV感染率为8．0％，对照组EBV感染率6．2％。AL组与对照组EBV—DNA阳性率无显著性差异（P〉0．05），MM组与对照EBV—DNA阳性率有显著性差异（P〈0．01），MM组与AL组EBV—DNA阳性率有显著性差异（P〈0．01）。结论AL患者的发病与EB病毒感染关系不大，MM患者的发病与EB病毒感染有关；应用荧光定量PCR方法对MM患者骨髓中，EBV—DNA舍量进行检测，对于揭示MM的发病与EBV感染之间的相关性提供了敏感可靠的检测方法。Objective To detect the bone marrow EBV- DNA by Fluorescence- quantitative PCR, in patients with acute leukemia（AL） or multiple myeloma（MM）, and investigate its clinical significance. Methods To measure bone marrow EBV- DNA with fluorescence quantitative PCR in 38 acute leukemia patients and 43 batients with acute multiple myeloma（MM） ,and measure the content in 32 Comparison eases of small cells hypeehromlc anemla and megaloblastie anemia. Results EBV infection rate in multiple myeloma is 58.1%. 8.0% in acute leukemia and 6.2% in the control group.The positive rate of EBV - DNA was.no significant difference between AL group and the control group（P〉 0. 05） .The positive rate of EBV- DNA has significant difference between MM group and the control group（P 〈 0.01 ） .The positive rate of EBV - DNA was significant difference between AL group and MM group（ P 〈 0. 01 ）. Conclusion The incidence of AL patients have little to do with EB virus intection then,then MM patients have incidence with EB virus infection;Detecting the bone marrow EBV - DNA content with fluorescence quantitative PCR in patients with muhiple myeloma（MM） is a sensitive and reliable detection method for revealing the correlation between the pathogetiesis of MM and EBV infection.

关 键 词：EB病毒 急性白血病 多发性骨髓瘤 DNA 

分 类 号：R733.3[医药卫生—肿瘤]